Fuisz Technologies to develop in-house OTCs and dietary supplement products.
This article was originally published in The Tan Sheet
Executive Summary
FUISZ HOPES TO BEGIN MARKETING IN-HOUSE OTC ANALGESICS, SUPPLEMENTS in early 1997. An OTC analgesic product using Fuisz Technologies' drug-delivery technology will be followed by calcium supplements and an OTC H2 antagonist. Fuisz announced plans Aug. 15 to expand its business beyond the development of drug delivery and food applications for other companies' products into the development of its own OTC products.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning